Morepen Laboratories Limited (MOREPENLAB) Share Price
NSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE083A01026
Key metrics
- Market Cap
- ₹6,317 Cr
- P/E Ratio
- 41.62
- EPS
- 2.77
- Book Value
- 22.76
- P/B Ratio
- 5.06
- ROE
- 7.61%
- ROCE
- 6.13%
- Debt / Equity
- 0.17
- Net Margin
- 5.27%
- Revenue Growth
- -0.14%
- Profit Growth
- -19.61%
- Dividend Yield
- 0.19%
- 52W High
- ₹115.98
- 52W Low
- ₹33.05
- Market Cap Band
- mid cap
- Face Value
- 2
Ratios computed from the annual results period ending 2026-03-31.
About Morepen Laboratories Limited
Morepen Laboratories Limited develops, manufactures, markets, and sells active pharmaceutical ingredients (APIs), branded and generic formulations, and home health products in India, the United States, and internationally. The company offers APIs for anti-histaminic, anti-asthmatic, anti-lipemic, anti-hypertensive, anti-diabetic, anti-coagulant, anti-ulcerative, and anti-depressant drugs; and home diagnostic products, such as air purifiers, sphygmomanometers, blood glucose test strips, blood pressure monitors, breathe free vaporizers, stethoscopes, digital thermometers, blood glucose monitors, nebulizers, heat belts, and pulse oximeters. It also provides OTC and healthcare products, including fever X for fever; Pain X for pain; Fiber-X for constipation; sat isabgol; Acidity X for acidity; Burnol, a first degree/minor burns cream; and formulations for nutrition and probiotics, gastroenterology, antibiotics, gynecology, anti-allergic, and central nervous system, as well as cardiology, diabetology, and nutraceuticals. The company offers over the counter products under the Dr. Morepen brand name. Morepen Laboratories Limited was incorporated in 1984 and is based in Gurugram, India.
- Headquarters
- Gurugram, India
- Promoter Holding
- 42.69%
The full Morepen Laboratories Limited analysis
Create a free account to open the complete MOREPENLAB deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.